Next steps for pharmaceutical nanotechnology

Journal of Pharmaceutical Innovation

Volumn 5, Issue 3, 2010, Pages 70-71

  Berkland, Cory ^a  

^a University of Kansas   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APREPITANT; FENOFIBRATE; NANOPARTICLE; PACLITAXEL; RAPAMYCIN; SUPERPARAMAGNETIC IRON OXIDE;

COLLOID; DRUG DELIVERY SYSTEM; DRUG MANUFACTURE; EDITORIAL; NANOTECHNOLOGY; PHARMACEUTICS; PRIORITY JOURNAL;

EID: 77958085961     PISSN: 18725120     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12247-010-9084-0     Document Type: Editorial

References (10)

1. H Rytting 2004 Int J Pharm 281 1 1:CAS:528:DC%2BD2cXmtFCmuro%3D 10.1016/j.ijpharm.2004.07.001 (Pubitemid 39024257)
2. V Wagner A Dullaart AK Bock A Zweck 2006 Nat Biotechnol 24 1211 1:CAS:528:DC%2BD28XhtVGgsrvI 10.1038/nbt1006-1211 17033654 (Pubitemid 44564760)
3. G Pasut FM Veronese 2009 Adv Drug Deliv Rev 61 1177 1:CAS:528: DC%2BD1MXhtlWhtL7P 10.1016/j.addr.2009.02.010 19671438
4. F Alexis E Pridgen LK Molnar OC Farokhzad 2008 Mol Pharm 5 505 1:CAS:528:DC%2BD1cXpt1Wlurs%3D 10.1021/mp800051m 18672949
5. J Mintorovitch K Shamsi 2000 Oncology (Williston Park) 14 37 1:STN:280:DC%2BD3M%2Fht1ynuw%3D%3D
6. J Hu KP Johnston RO Williams 3rd 2004 Drug Dev Ind Pharm 30 233 10.1081/DDC-120030422 15109023 (Pubitemid 38451748)
7. N El-Gendy C Berkland 2009 Pharm Res 26 1752 1:CAS:528: DC%2BD1MXltlylsrg%3D 10.1007/s11095-009-9886-2 19415471
8. N El-Gendy EM Gorman EJ Munson C Berkland 2009 J Pharm Sci 98 2731 1:CAS:528:DC%2BD1MXns1eqsbc%3D 10.1002/jps.21630 19130469
9. LJ Peek CR Middaugh C Berkland 2008 Adv Drug Deliv Rev 60 915 1:CAS:528:DC%2BD1cXlslagu7Y%3D 10.1016/j.addr.2007.05.017 18325628
10. KA Whitehead R Langer DG Anderson 2009 Nat Rev Drug Discov 8 129 1:CAS:528:DC%2BD1MXhtFOqt70%3D 10.1038/nrd2742 19180106